Bile Acids, Nuclear Receptors and Cytochrome P450

被引:29
作者
Jurica, J. [1 ,2 ]
Dovrtelova, G. [1 ]
Noskova, K. [1 ]
Zendulka, O. [1 ]
机构
[1] Masaryk Univ, Fac Med, Dept Pharmacol, Kamenice 5, Brno 62500, Czech Republic
[2] Masaryk Univ, Fac Sci, Dept Biochem, Brno, Czech Republic
关键词
Bile acids; FXR; PXR; Cytochrome P450; FARNESOID-X-RECEPTOR; VITAMIN-D-RECEPTOR; STEROL 27-HYDROXYLASE GENE; URSODEOXYCHOLIC ACID; CHOLESTEROL; 7-ALPHA-HYDROXYLASE; TRANSCRIPTIONAL REGULATION; OBETICHOLIC ACID; HUMAN INTESTINE; DOWN-REGULATION; CYP3A4; GENE;
D O I
10.33549/physiolres.933512
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
This review summarizes the importance of bile acids (BA) as important regulators of various homeostatic mechanisms with detailed focus on cytochrome P450 (CYP) enzymes. In the first part, synthesis, metabolism and circulation of BA is summarized and BA are reviewed as physiological ligands of nuclear receptors which regulate transcription of genes involved in their metabolism, transport and excretion. Notably, PXR, FXR and VDR are the most important nuclear receptors through which BA regulate transcription of CYP genes involved in the metabolism of both BA and xenobiotics. Therapeutic use of BA and their derivatives is also briefly reviewed. The physiological role of BA interaction with nuclear receptors is basically to decrease production of toxic non-polar BA and increase their metabolic turnover towards polar BA and thus decrease their toxicity. By this, the activity of some drug-metabolizing CYPs is also influenced what could have clinically relevant consequences in cholestatic diseases or during the treatment with BA or their derivatives.
引用
收藏
页码:S427 / S440
页数:14
相关论文
共 102 条
[1]   Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis [J].
Adorini, Luciano ;
Pruzanski, Mark ;
Shapiro, David .
DRUG DISCOVERY TODAY, 2012, 17 (17-18) :988-997
[2]  
American Society of Health System Pharmacists, 2016, DYNAMED
[3]  
BalandraudPieri N, 1997, DRUG METAB DISPOS, V25, P912
[4]   Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4-dependent pharmacokinetics in humans [J].
Becquemont, Laurent ;
Glaeser, Hartmut ;
Drescher, Siegfried ;
Hitzl, Monika ;
Simon, Nicolas ;
Murdter, Thomas E. ;
Heinkele, Georg ;
Hofmann, Ute ;
Schaefer, Christian ;
Burk, Oliver ;
Verstuyft, Celine ;
Eichelbaum, Michel ;
Fromm, Martin F. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (05) :449-460
[5]   The interaction between bacteria and bile [J].
Begley, M ;
Gahan, CGM ;
Hill, C .
FEMS MICROBIOLOGY REVIEWS, 2005, 29 (04) :625-651
[6]   Constitutive Androstane Receptor-Mediated Changes in Bile Acid Composition Contributes to Hepatoprotection from Lithocholic Acid-Induced Liver Injury in Mice [J].
Beilke, Lisa D. ;
Aleksunes, Lauren M. ;
Holland, Ricky D. ;
Besselsen, David G. ;
Beger, Rick D. ;
Klaassen, Curtis D. ;
Cherrington, Nathan J. .
DRUG METABOLISM AND DISPOSITION, 2009, 37 (05) :1035-1045
[7]   New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond [J].
Beuers, Ulrich ;
Trauner, Michael ;
Jansen, Peter ;
Poupon, Raoul .
JOURNAL OF HEPATOLOGY, 2015, 62 :S25-S37
[8]   EASL Clinical Practice Guidelines: Management of cholestatic liver diseases [J].
Beuers, Ulrich ;
Boberg, Kirsten M. ;
Chapman, Roger W. ;
Chazouilleres, Olivier ;
Invernizzi, Pietro ;
Jones, David E. J. ;
Lammert, Frank ;
Pares, Albert ;
Trauner, Michael .
JOURNAL OF HEPATOLOGY, 2009, 51 (02) :237-267
[9]   Reduction of thyroid hormones triggers down-regulation of hepatic CYP2B through nuclear receptors CAR and TR in a rat model of acute stroke [J].
Bing, Yuntao ;
Zhu, Siying ;
Jiang, Kun ;
Dong, Guicheng ;
Li, Jie ;
Yang, Zheqiong ;
Yang, Jing ;
Yue, Jiang .
BIOCHEMICAL PHARMACOLOGY, 2014, 87 (04) :636-649
[10]   Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity [J].
Buryova, Halka ;
Chalupsky, Karel ;
Zbodakova, Olga ;
Kanchev, Ivan ;
Jirouskova, Marketa ;
Gregor, Martin ;
Sedlacek, Radislav .
BMC GASTROENTEROLOGY, 2013, 13